76 related articles for article (PubMed ID: 12490884)
1. First bite.
Gorrell MD
Nat Struct Biol; 2003 Jan; 10(1):3-5. PubMed ID: 12490884
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog.
Rasmussen HB; Branner S; Wiberg FC; Wagtmann N
Nat Struct Biol; 2003 Jan; 10(1):19-25. PubMed ID: 12483204
[TBL] [Abstract][Full Text] [Related]
3. Structural requirements for catalysis, expression, and dimerization in the CD26/DPIV gene family.
Ajami K; Abbott CA; Obradovic M; Gysbers V; Kähne T; McCaughan GW; Gorrell MD
Biochemistry; 2003 Jan; 42(3):694-701. PubMed ID: 12534281
[TBL] [Abstract][Full Text] [Related]
4. Diprolyl nitriles as potent dipeptidyl peptidase IV inhibitors.
Zhao G; Taunk PC; Magnin DR; Simpkins LM; Robl JA; Wang A; Robertson JG; Marcinkeviciene J; Sitkoff DF; Parker RA; Kirby MS; Hamann LG
Bioorg Med Chem Lett; 2005 Sep; 15(18):3992-5. PubMed ID: 16046120
[TBL] [Abstract][Full Text] [Related]
5. Crystal structures of DPP-IV (CD26) from rat kidney exhibit flexible accommodation of peptidase-selective inhibitors.
Longenecker KL; Stewart KD; Madar DJ; Jakob CG; Fry EH; Wilk S; Lin CW; Ballaron SJ; Stashko MA; Lubben TH; Yong H; Pireh D; Pei Z; Basha F; Wiedeman PE; von Geldern TW; Trevillyan JM; Stoll VS
Biochemistry; 2006 Jun; 45(24):7474-82. PubMed ID: 16768443
[TBL] [Abstract][Full Text] [Related]
6. Dipeptidyl peptidase IV activity and/or structure homologs: contributing factors in the pathogenesis of rheumatoid arthritis?
Sedo A; Duke-Cohan JS; Balaziova E; Sedova LR
Arthritis Res Ther; 2005; 7(6):253-69. PubMed ID: 16277701
[TBL] [Abstract][Full Text] [Related]
7. Structure-function properties of prolyl oligopeptidase family enzymes.
Rea D; Fülöp V
Cell Biochem Biophys; 2006; 44(3):349-65. PubMed ID: 16679522
[TBL] [Abstract][Full Text] [Related]
8. The crystal structure of human dipeptidyl peptidase IV (DPPIV) complex with diprotin A.
Hiramatsu H; Yamamoto A; Kyono K; Higashiyama Y; Fukushima C; Shima H; Sugiyama S; Inaka K; Shimizu R
Biol Chem; 2004 Jun; 385(6):561-4. PubMed ID: 15255191
[TBL] [Abstract][Full Text] [Related]
9. Discovery, SAR, and X-ray structure of novel biaryl-based dipeptidyl peptidase IV inhibitors.
Qiao L; Baumann CA; Crysler CS; Ninan NS; Abad MC; Spurlino JC; Desjarlais RL; Kervinen J; Neeper MP; Bayoumy SS; Williams R; Deckman IC; Dasgupta M; Reed RL; Huebert ND; Tomczuk BE; Moriarty KJ
Bioorg Med Chem Lett; 2006 Jan; 16(1):123-8. PubMed ID: 16236500
[TBL] [Abstract][Full Text] [Related]
10. In silico fragment-based discovery of DPP-IV S1 pocket binders.
Rummey C; Nordhoff S; Thiemann M; Metz G
Bioorg Med Chem Lett; 2006 Mar; 16(5):1405-9. PubMed ID: 16321524
[TBL] [Abstract][Full Text] [Related]
11. Rigidity and flexibility of dipeptidyl peptidase IV: crystal structures of and docking experiments with DPIV.
Engel M; Hoffmann T; Manhart S; Heiser U; Chambre S; Huber R; Demuth HU; Bode W
J Mol Biol; 2006 Jan; 355(4):768-83. PubMed ID: 16330047
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of dipeptidyl-peptidase IV catalyzed peptide truncation by Vildagliptin ((2S)-{[(3-hydroxyadamantan-1-yl)amino]acetyl}-pyrrolidine-2-carbonitrile).
Brandt I; Joossens J; Chen X; Maes MB; Scharpé S; De Meester I; Lambeir AM
Biochem Pharmacol; 2005 Jul; 70(1):134-43. PubMed ID: 15907807
[TBL] [Abstract][Full Text] [Related]
13. Selectivity among dipeptidyl peptidases of the S9b family.
Bjelke JR; Kanstrup AB; Rasmussen HB
Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(4):3-7. PubMed ID: 17543192
[TBL] [Abstract][Full Text] [Related]
14. Design and discovery of a novel dipeptidyl-peptidase IV (CD26)-based prodrug approach.
García-Aparicio C; Bonache MC; De Meester I; San-Félix A; Balzarini J; Camarasa MJ; Velazquez S
J Med Chem; 2006 Aug; 49(17):5339-51. PubMed ID: 16913724
[TBL] [Abstract][Full Text] [Related]
15. Hemorphins: substrates and/or inhibitors of dipeptidyl peptidase IV. Hemorphins N-terminus sequence influence on the interaction between hemorphins and DPPIV.
Cohen M; Fruitier-Arnaudin I; Piot JM
Biochimie; 2004 Jan; 86(1):31-7. PubMed ID: 14987798
[TBL] [Abstract][Full Text] [Related]
16. A three-dimensional pharmacophore model for dipeptidyl peptidase IV inhibitors.
Lu IL; Tsai KC; Chiang YK; Jiaang WT; Wu SH; Mahindroo N; Chien CH; Lee SJ; Chen X; Chao YS; Wu SY
Eur J Med Chem; 2008 Aug; 43(8):1603-11. PubMed ID: 18207285
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, kinetic evaluation, and utilization of a biotinylated dipeptide proline diphenyl phosphonate for the disclosure of dipeptidyl peptidase IV-like serine proteases.
Gilmore BF; Carson L; McShane LL; Quinn D; Coulter WA; Walker B
Biochem Biophys Res Commun; 2006 Aug; 347(1):373-9. PubMed ID: 16824486
[TBL] [Abstract][Full Text] [Related]
18. 'Dipeptidyl peptidase-IV activity and/or structure homologs' (DASH) in growth-modulated glioma cell lines.
Sedo A; Busek P; Scholzová E; Malík R; Vlasicová K; Janácková S; Mares V
Biol Chem; 2004 Jun; 385(6):557-9. PubMed ID: 15255190
[TBL] [Abstract][Full Text] [Related]
19. From the bench to the bedside: dipeptidyl peptidase IV inhibitors, a new class of oral antihyperglycemic agents.
Pei Z
Curr Opin Drug Discov Devel; 2008 Jul; 11(4):512-32. PubMed ID: 18600568
[TBL] [Abstract][Full Text] [Related]
20. Probing prime substrate binding sites of human dipeptidyl peptidase-IV using competitive substrate approach.
Kopcho LM; Kim YB; Wang A; Liu MA; Kirby MS; Marcinkeviciene J
Arch Biochem Biophys; 2005 Apr; 436(2):367-76. PubMed ID: 15797249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
